Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wound dressing downclassification

This article was originally published in The Gray Sheet

Executive Summary

Nonreabsorbable gauze/sponges for external use, hydrophilic wound dressings, occlusive wound dressings, and hydrogel wound dressings are downclassified to Class I, 510(k)-exempt status in an Oct. 4 final rule. The General and Plastic Surgery Devices Panel recommended the downclassification at a November 1998 meeting. The Health Industry Manufacturers Association had recommended that porcine wound dressings also be Class I, 510(k)-exempt (1"The Gray Sheet" Nov. 16, 1998, p. 8). FDA plans to address porcine wound dressing in the future. Some panel members had raised concerns about the potential risk for the transmission of infectious materials in wound dressings that are composed of materials derived of animal-based sources

You may also be interested in...



Five Wound Dressing Categories Should Be Class I, 510(k) Exempt - HIMA

The Health Industry Manufacturers Association is proposing that FDA designate five types of unclassified preamendments wound dressings as Class I devices exempt from 510(k) requirements.

ASTM Developing Standard To Tackle Dried Blood On Steel Devices

ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.

Executives On The Move: CEOs Named At Elevation Oncology, PainReform Ltd

Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel